DCM
RXST icon

Driehaus Capital Management’s RxSight RXST Stock Holding History

Driehaus Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-472,349
Closed -$23.3M – 442
2024
Q3 		$23.3M Sell
472,349
-233,813
-33% -$12M 0.2% 152
2024
Q2 		$42.5M Buy
706,162
+302,367
+75% +$17.3M 0.41% 76
2024
Q1 		$20.8M Sell
403,795
-125,425
-24% -$6.16M 0.21% 146
2023
Q4 		$21.3M Sell
529,220
-64,738
-11% -$1.9M 0.26% 126
2023
Q3 		$16.6M Buy
593,958
+121,363
+26% +$3.62M 0.22% 152
2023
Q2 		$13.6M Buy
472,595
+2,705
+0.6% +$60.2K 0.17% 185
2023
Q1 		$7.84M Buy
+469,890
New +$6.64M 0.11% 252

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Driehaus Capital Management's RXST Position: Q4 2024 in Review

Driehaus Capital Management sold out of RxSight (RXST) in Q4 2024, closing a stake of 472,349 shares — an estimated $23.3M sold.

Driehaus Capital Management first reported a position in RXST in Q1 2023 and held it in 7 quarters. The position peaked at $42.5M in Q2 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • Driehaus Capital Management reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 472,349 RxSight shares in Q4 2024, an estimated $23.3M.
  • Driehaus Capital Management first reported a position in RxSight in Q1 2023 and held it in 7 quarters.
  • Driehaus Capital Management's RxSight position peaked at $42.5M in Q2 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Driehaus Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.